Biocure Technology Inc (CURE.X) Financial Statements
Biocure Technology Inc Financial Overview
Biocure Technology Inc's market cap is currently $1.11M. The company's EPS TTM is ―; its P/E ratio is -8.21; Biocure Technology Inc is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ― | ― | ― | ― | ― |
| Gross Profit | ― | ― | ― | ― | ― |
| Operating Income | $ -1.08M | $ -696.24K | $ -3.90M | $ -2.97M | $ -4.60M |
| EBITDA | $ -1.49M | $ -403.40K | $ -1.80M | $ -2.78M | $ -4.61M |
| Net Income | $ -1.81M | $ -1.45M | $ -1.13M | $ -2.95M | $ -4.74M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ― | ― | ― | ― | ― |
| Total Assets | $ 1.98M | $ 2.08M | $ 4.15M | $ 4.55M | $ 4.58M |
| Total Debt | $ 41.88K | $ 81.19K | $ 3.79M | $ 3.99M | $ 3.65M |
| Net Debt | $ 37.64K | $ 43.52K | $ 3.63M | $ 3.94M | $ 3.52M |
| Total Liabilities | $ 373.24K | $ 4.41M | $ 5.01M | $ 6.86M | $ 4.99M |
| Stockholders' Equity | ― | ― | ― | ― | ― |
| Cash Flow | |||||
| Free Cash Flow | ― | $ -825.92K | $ -1.08M | $ -1.31M | $ -2.68M |
| Operating Cash Flow | ― | ― | ― | ― | ― |
| Investing Cash Flow | ― | ― | ― | ― | ― |
| Financing Cash Flow | ― | ― | ― | ― | ― |
Currency in USD